Chris Lange
6 min read
Quick Read
-
Generating $25,000 annually from blue chips like JNJ (1.96%) or PG (2.99%) demands $714,000 to $836,000 in capital but delivers 64 to 70 years of consecutive dividend growth.
-
Realty Income (O) at 5.3% cuts the required capital to $500,000, but its REIT structure makes it vulnerable when 10-year Treasury yields sit near their trailing highs.
-
A dividend growing 6-8% annually doubles income in 9-12 years without adding capital, making compounders like JNJ outperform static high-yielders over time.
-
Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Johnson & Johnson didn’t make the cut. Enter your email to see the names that beat JNJ. The report is free. Enter your email and see if any of your stocks made the cut.
The goal here is $25,000 a year in dividend income. Working backward from a paycheck number is more useful than starting with a lump sum because it forces the question every income investor eventually asks: what is the price of admission at each yield level, and what am I giving up to lower that price? The equation never changes. Income target divided by yield equals capital required. Yield does the work of shrinking the number, but every basis point of extra yield usually comes with a piece of balance-sheet or growth risk attached.
Against a benchmark 10-year Treasury yield of 4.83%, dividend stocks now have to earn their spot in an income portfolio on more than yield alone. Here is what $25,000 looks like at three tiers, using named US-listed dividend payers with verified current yields.
Conservative Tier: Blue Chip Dividend Growers Near 2% to 3%
This is the sleep-at-night tier. Payout coverage is deep, free cash flow funds the dividend with room to spare, and the tradeoff is that capital required is highest.
Free Report, Just Released
Why Didn’t JNJ Make The Top 10 List?
24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.
And JNJ didn’t make the cut!
The report is free, and you can see why we think each stock is a top investment today.
Enter Your Email and See the Ten →
Johnson & Johnson (NYSE:JNJ) yields 1.96% at $267.59, with an annualized forward dividend of $5.36 after 64 consecutive years of dividend growth. Fiscal 2025 operating cash flow of $24.53 billion covered a $12.38 billion dividend payout roughly two times over. The risk here is pharma pipeline concentration and ongoing talc litigation exposure.
